Skip to main content
Premium Trial:

Request an Annual Quote

Pharmaxis Taps Dotmatics Software for Preclinical Research Data Management


Cheminformatics firm Dotmatics said this week that Pharmaxis, a specialty pharmaceutical company, has selected its software suite to support preclinical research data management.

Dotmatics' product suite includes Browser, an interactive dashboard that allows users to integrate and view research data from multiple sources; and Vortex, an application that provides an environment for predictive analytics, visualization, and data analysis.

Pharmaxis, which focuses on developing therapies for chronic respiratory diseases, selected the Dotmatics platform after considering options from a number of software companies, Wolfgang Jarolimek, Pharmaxis's head of drug discovery, said in a statement.

Features that informed its decision to go with Dotmatics's tools include support for analysis of plate-based data, the ability to accept data uploads from Excel spreadsheets, and the ability to enable Pharmaxis's scientists to drill down into large datasets, he said.

Last September, UK-based Dotmatics moved its East Coast office to a large facility in Boston, Mass., to make room for its expanding sales and support teams as well as new hires. At the time, the company also said it was looking to increase its footprint in markets outside the life science including the chemical-research space, oil and gas industries, and consumer products (BI 9/9/2011).

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.